Can cadmium worsen amyloid and tau neurotoxicity?

Cadmium is a biologically credible neurotoxicant: experimental studies support its capacity to perturb redox balance, mitochondria, inflammatory signaling, and—under some conditions—blood–brain-barrier (BBB) structure. Its proposed role in worsening amyloid-β and tau toxicity is plausible, but not established as a causal pathway in humans.

Experimental and mechanistic evidence

• Cadmium increased brain reactive oxygen species (ROS), inflammatory mediators, and microglial activation in rat studies. In primary rat microglia, ROS was accompanied by redox-sensitive NF-κB/AP-1 activation, providing a coherent ROS–microglia–inflammation pathway.
• Neuronal-cell experiments link cadmium to mitochondrial dysfunction, including respiratory/ATP disruption and ROS generation. These changes could compound neuronal vulnerability and facilitate kinase dysregulation relevant to tau phosphorylation.
• BBB-related injury is supported in selected models: cadmium disrupted ZO-1 localization and cytoskeletal organization in rat brain endothelial cells, with ROS, endoplasmic-reticulum stress, and caspase-3 implicated. Zebrafish embryos showed increased permeability and cerebral hemorrhage. However, tested human brain endothelial cells showed oxidative stress without significant dextran-permeability or ZO-2 changes, indicating exposure- and model-dependence.

Amyloid and tau relevance

• In experimental mice, cadmium increased BACE1, amyloid-β species, Aβ1–42, and plaque burden, while reducing non-amyloidogenic APP processing. Chronic low-dose exposure also increased tau hyperphosphorylation.
• Oxidative stress, mitochondrial injury, neuroinflammation, and BBB disruption offer interconnected routes through which cadmium could amplify amyloid- and tau-related neuronal injury. Proposed tau mechanisms include oxidative/kinase dysregulation and possible interaction with tau’s R3 repeat.
• Human evidence is limited: higher serum cadmium was cross-sectionally associated with lower CSF amyloid-β42/40 and higher total and phosphorylated tau in mild cognitive impairment, but cannot establish causation.

Bottom line

• Cadmium can induce several experimentally supported neurotoxic processes and is plausibly capable of aggravating amyloid and tau pathology; whether these mechanisms causally accelerate Alzheimer disease in people remains unproven.